Cargando…
Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC
Lung cancer is one of the most common tumors and its treatment is still inefficient. In our previous work we proved that ciprofloxacin has a different influence on five cancer cell lines. Here, we aimed to compare the biological effect of ciprofloxacin on cell lines representing different responses...
Autores principales: | KLOSKOWSKI, TOMASZ, GURTOWSKA, NATALIA, OLKOWSKA, JOANNA, NOWAK, JAKUB MARCIN, ADAMOWICZ, JAN, TWORKIEWICZ, JAKUB, DĘBSKI, ROBERT, GRZANKA, ALINA, DREWA, TOMASZ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583647/ https://www.ncbi.nlm.nih.gov/pubmed/23042104 http://dx.doi.org/10.3892/ijo.2012.1653 |
Ejemplares similares
-
Schwann cells – a new hope in tissue engineered urinary bladder innervation. A method of cell isolation
por: Adamowicz, Jan, et al.
Publicado: (2011) -
Ablative therapies for small renal tumors
por: Adamowicz, Jan, et al.
Publicado: (2013) -
Adipose-Derived Stem Cells as a Tool in Cell-Based Therapies
por: Bajek, Anna, et al.
Publicado: (2016) -
The relationship of cancer stem cells in urological cancers
por: Adamowicz, Jan, et al.
Publicado: (2013) -
Do Mesenchymal Stem Cells Modulate the Milieu of Reconstructed Bladder Wall?
por: Pokrywczynska, Marta, et al.
Publicado: (2013)